, Tracking Stock Market Picks
Enter Symbol:

up 65.75 %

PHARMERICA CORPORATION (PMC) rated Overweight with price target $25 by Thomas Weisel

Posted on: Friday,  Apr 23, 2010  8:25 AM ET by Thomas Weisel

Thomas Weisel rated Overweight PHARMERICA CORPORATION (NYSE: PMC) on 04/23/2010, when the stock price was $20.12. Since
then, PHARMERICA CORPORATION has gained 65.76% as of 10/09/2015's recent price of $33.35.
If you would have followed this Thomas Weisel's recommendation on PMC, you would have gained 65.75% of your investment in 1995 days.

PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities and provides management pharmacy services to hospitals. It operates more than 100 institutional pharmacies in 40 states. The Company also provides pharmacy management services to 84 hospitals in the United States. The Company operates in two business segments: institutional pharmacies, which provides pharmacy services to nursing centers and other healthcare providers, and the hospital pharmacy management business, which provides management services to Kindred Healthcare, Inc.?s (Kindred) hospitals. On July 9, 2008, the Company purchased the 49% minority interest held by a third-party in its joint ventures. On November 1, 2008, the Company acquired an institutional pharmacy business providing medications, pharmacy and medical supplies and services to residents of skilled nursing homes.

At Thomas Weisel Partners, the role of Research is to contribute to our clients' decision process in ways that lead to better investment decisions. We cover the key growth sectors of the economy including Consumer, Energy, Financial Services, Healthcare, Internet, Media & Telecom, Metals & Mining and Technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/23/2010 8:25 AM Buy
20.12 25.00
as of 12/31/2010
1 Week down  -3.04 %
1 Month up  5.61 %
3 Months up  20.35 %
1 YTD down  -42.99 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy